Seeing Is Believing
Currently out of the existing stock ratings of Adam Maeder, 200 are a BUY (72.73%), 68 are a HOLD (24.73%), 7 are a SELL (2.55%).
Analyst Adam Maeder, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 60.45% that have a potential upside of 29.84% achieved within 96 days.
Adam Maeder’s has documented 551 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on INSP, Inspire Medical Systems at 05-Aug-2025.
Analyst best performing recommendations are on RBOT (VICARIOUS SURGICAL).
The best stock recommendation documented was for RBOT (VICARIOUS SURGICAL) at 11/13/2024. The price target of $10.5 was fulfilled within 1 day with a profit of $1.35 (14.75%) receiving and performance score of 147.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$13
2 years 6 months 18 days ago
(23-Jan-2023)
1/2 (50%)
$0.16 (1.63%)
70
Hold
$10
$10
2 years 7 months 6 days ago
(04-Jan-2023)
3/4 (75%)
$0.12 (1.21%)
193
Hold
$10
$14
2 years 8 months 12 days ago
(30-Nov-2022)
1/5 (20%)
$-0.13 (-1.28%)
13
Buy
$9
$-1 (-10.00%)
$13
3 years 3 months 6 days ago
(04-May-2022)
1/3 (33.33%)
$3.44 (61.87%)
209
Buy
$12
$2 (20.00%)
$14
3 years 5 months 19 days ago
(23-Feb-2022)
9/13 (69.23%)
$6.64 (123.88%)
124
Which stock is Adam Maeder is most bullish on?
Which stock is Adam Maeder is most reserved on?
What Year was the first public recommendation made by Adam Maeder?